How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/1wipv-2sipv.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

1wIPV+2sIPV — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1wIPV+2sIPV (1wIPV+2sIPV) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated polio vaccine (IPV). Area: Immunology / Infectious Disease.

marketed Inactivated polio vaccine (IPV) Poliovirus types 1, 2, and 3 antigens Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

1wIPV+2sIPV (1wIPV+2sIPV) — Sinovac Biotech Co., Ltd. This is an inactivated polio vaccine combining one dose of whole-virus IPV with two doses of split-virus IPV to provide immunization against poliovirus types 1, 2, and 3.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
1wIPV+2sIPV TARGET	1wIPV+2sIPV	Sinovac Biotech Co., Ltd	marketed	Inactivated polio vaccine (IPV)	Poliovirus types 1, 2, and 3 antigens
fIPV (0.1 mL) ID	fIPV (0.1 mL) ID	Centers for Disease Control and Prevention	marketed	vaccine	poliovirus types 1, 2, and 3 antigens
2wIPV+1sIPV	2wIPV+1sIPV	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3 antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated polio vaccine (IPV) class)

Sinovac Biotech Co., Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 1wIPV+2sIPV — Competitive Intelligence Brief. https://druglandscape.com/ci/1wipv-2sipv. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing